Viewing Study NCT00209651


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-07-03 @ 12:04 AM
Study NCT ID: NCT00209651
Status: UNKNOWN
Last Update Posted: 2007-11-01
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
Sponsor: Hokkaido Gastrointestinal Cancer Study Group
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HGCSG0302
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View